ImmunoBreast - A Phase Ib Study

Clinical trial NCT04609215 · UNKNOWN

Trial details

NCT number: NCT04609215
Sponsor: Henrik Ditzel
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Breast Cancer Metastatic Breast Cancer

Start date: 2020-04-21
Primary completion: 2023-05-21
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.